Home › Coronary Artery Disease › Nebraska › Lincoln
Coronary Artery Disease clinical trials in Lincoln, NE
5 studies for Coronary Artery Disease are looking for participants at sites in and around Lincoln (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Bryan Heart, Lincoln
- CHI Health Nebraska Heart, Lincoln
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- GSR Enterprises, Inc., Lincoln
Randomization of Single vs Multiple Arterial Grafts
Recruiting
- Nebraska Heart Hospital, Lincoln
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Recruiting
- Nebraska Heart Hospital, Lincoln
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Recruiting
- Bryan Heart, Lincoln
About Coronary Artery Disease
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
More about Coronary Artery Disease on MedlinePlus
Coronary Artery Disease trials in other cities
- New York City, NY21 studies
- Boston, MA16 studies
- Dallas, TX15 studies
- Atlanta, GA15 studies
- Jacksonville, FL14 studies
- Minneapolis, MN13 studies
- Cleveland, OH13 studies
- Nashville, TN11 studies
- Columbus, OH10 studies
- Durham, NC9 studies
- Philadelphia, PA8 studies
- Houston, TX8 studies
Other studies in Lincoln
- Non-Small Cell Lung Cancer16 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Schizophrenia4 studies
- Breast Cancer4 studies
- Colorectal Cancer4 studies
- Obesity4 studies
- Amyotrophic Lateral Sclerosis3 studies
- Cancer (all types)3 studies
- Multiple Myeloma3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.